Implementation of Preemptive Clinical Pharmacogenetics

Описание: Mary V. Relling, Pharm.D. joined St. Jude as a faculty member in 1988, and in 2003 was named chair of the Department of Pharmaceutical Sciences. She is also a professor at The University of Tennessee in the colleges of Medicine and Pharmacy. Her primary interests are in treatment of childhood leukemia and pharmacogenetics of anti-leukemic therapy. Dr. Relling is one of the principal investigators within the National Institutes of Health Pharmacogenomics Research Network and co-founder of the Clinical Pharmacogenetics Implementation Consortium.

For more information, visit us at: http://individualizingmedicineconfere...